Fierce Pharma
MARCH 1, 2024
Moderna is laying off employees within its manufacturing unit, with the move tied to a resizing of its COVID production work. | Moderna is laying off some employees within its manufacturing unit after shaving COVID production costs. The company previously disclosed plans to rightsize its COVID vaccine production footprint.
MedCity News
MARCH 1, 2024
The Pharmacy Guild recently launched and aims to create the first national pharmacy union in the U.S. But it has a difficult road ahead going up against giants like Walgreens and CVS. Still, its organizers expect the union to be successful.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
MARCH 1, 2024
It’s time to add another vaccine to the shortage list in the U.S. | It’s time to add another vaccine to the shortage list in the United States as the CDC has urged healthcare providers to conserve their supply of tetanus shots. The warning from the national public health agency comes after one of the two providers of tetanus shots in the U.S., MassBiologics, discontinued production of its tetanus and diphtheria vaccine.
pharmaphorum
MARCH 1, 2024
Pfizer says new oncology division will generate eight new blockbusters by 2030, in first R&D update after its $43bn takeover of Seagen.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
MARCH 1, 2024
Less than three weeks after a Texas judge tossed a lawsuit b | Less than three weeks after a Texas judge tossed a lawsuit by industry lobbying group PhRMA that challenged the constitutionality of the Inflation Reduction Act, a federal court in Delaware has done the same with a similar action brought by AstraZeneca.
MedCity News
MARCH 1, 2024
WebMD acquired the operating assets of Healthwise, a nonprofit provider of health education content and patient engagement tools. The deal follows another acquisition WebMD made in the patient engagement space in 2020. According to Ann Bilyew, WebMD’s senior vice president of health, the company is now “the indisputable market leader in providing patient education to both providers and payers.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
MARCH 1, 2024
Rare Disease Day saw the debut of a film that aims to raise awareness of cerebral adrenoleukodystrophy (cALD), a devastating and fatal condition with no pharmacological treatments available.
Fierce Pharma
MARCH 1, 2024
The FDA recently asked the six marketed CAR-T therapies to add a new boxed warning item on their labels to reflect the risk of secondary T-cell cancers. | The FDA recently asked the six marketed CAR-T therapies to add a new boxed warning item on their labels to reflect the risk of secondary T-cell cancers. This week on "The Top Line," Fierce Pharma’s Angus Liu talks with regulatory experts to understand the rationale behind the FDA’s decision and to discuss its implications for CAR-T c
MedCity News
MARCH 1, 2024
The benefits of healthcare data are undeniable—more informed decisions, better diagnoses, enhanced operational efficiency, improved patient satisfaction—but all that data also creates significant challenges.
Fierce Pharma
MARCH 1, 2024
With a new FDA nod, BeiGene has filled the follicular lymphoma approval gap for BTK inhibitors. | BeiGene has filled the follicular lymphoma gap for BTK inhibitors with an FDA approval for Brukinsa about a year after AbbVie and Johnson & Johnson's Imbruvica stumbled in a phase 3 trial. But tough competition with CAR-T therapies and bispecifics lies ahead.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
European Pharmaceutical Review
MARCH 1, 2024
Technology trends Current technology trends are influencing consumer behaviour and reshaping the way industry operates. Although pharma companies are working steadily to leverage the power of data and become more agile and resilient, there is still room for improvement. The post 2024 Pharmaceutical industry trends – discover the latest pharma quality and manufacturing trends appeared first on European Pharmaceutical Review.
Fierce Pharma
MARCH 1, 2024
North Carolina has proved an attractive destination for biopharma companies large and small in recent years, ginning up investments and site commitments from the likes of Eli Lilly, Fujifilm Diosyn | North Carolina has proved an attractive destination for biopharma companies large and small in recent years, ginning up investments and site commitments from the likes of Eli Lilly, Fujifilm Diosynth, Thermo Fisher and Amgen.
MedCity News
MARCH 1, 2024
FogPharma’s lead program is a peptide that blocks a difficult-to-drug pathway inside of cells. The new financing will go toward an ongoing Phase 1/2 study in advanced solid tumors and support development of pipeline programs for other elusive cancer targets.
European Pharmaceutical Review
MARCH 1, 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the first product via its new International Recognition Procedure (IRP). The approval was for a new formulation for XGEVA (denosumab), to prevent serious bone-related complications caused by bone metastasis in adults and to treat giant cell tumour of bone in adults and adolescents.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmaceutical Technology
MARCH 1, 2024
Experts say that dry granulation is 10x more efficient than wet granulation, which could make substantial progress towards making this pharmaceutical process greener.
European Pharmaceutical Review
MARCH 1, 2024
A new £11.5 million investment is set to support the development of innovative solutions to drive advancements in sustainable biomanufacturing in the UK. The UK Research and Innovation ( UKRI ) is backing 21 cross-sector collaborations designed to generate innovation, commercialisation and growth in this area. UKRI highlighted that overall, these investments will “enhance the UK’s global competitiveness by supporting research and innovation that leads to new and disruptive biomanufacturing proce
Impetus Digital
MARCH 1, 2024
To set their Phase II clinical trial of a novel anti-cancer compound up for success, our client sought early multidisciplinary insights on current unmet needs, as well as feedback on their preclinical and early Phase I data and proposed protocol, from three parallel groups comprising oncologists, oncology nurses, and patients. For each group, we executed three virtual touchpoints.
MedCity News
MARCH 1, 2024
A surge in cloud adoption by healthcare organizations brings new challenges, particularly in safeguarding data across diverse providers while meeting regulatory frameworks.
pharmaphorum
MARCH 1, 2024
A new formulation of Amgen’s cancer treatment Xgeva is the first to be approved in the UK under a new procedure designed to speed up access to new therapies.
Pharmaceutical Technology
MARCH 1, 2024
During 2023, funding decreased by 43.2% compared to 2022 and by 52.3% compared to 2021, attributed to macroeconomic pressures.
pharmaphorum
MARCH 1, 2024
German biotech 4SC has filed its oral HDAC inhibitor Kinselby as a maintenance therapy for rare cancer CTCL in the EU
MedCity News
MARCH 1, 2024
Wellness-oriented consumers are seeking products and practices backed not only by promises but by scientific credibility.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmaTimes
MARCH 1, 2024
Different factors, such as illness duration and virus variant, impacted patients cognitive abilities
European Pharmaceutical Review
MARCH 1, 2024
Articles included in Issue 1 of European Pharmaceutical Review include: FOREWORD Validation of analytical procedures – ICH Q2(R2) David Elder, David P Elder Consultancy REGULATORY INSIGHT The EU pharmaceutical reform: tweaks to marketing authorisation procedures Vladimir Murovec, Osborne Clarke SEPARATION & PURIFICATION IDF Fractionation, purification and downstream processing: the path to commercialisation Rob Abbenhuis, Ardena PAT Process analytics for the new era of continuous RNA manufac
PharmaTimes
MARCH 1, 2024
TMR-CT will help doctors select treatment and predict the spread of lung cancer in patients
European Pharmaceutical Review
MARCH 1, 2024
API method development and testing at Polpharma API As a key player in the Polish pharmaceutical market and a prominent drug manufacturer in Central and Eastern Europe, Polpharma API exports medicinal products to 35 markets and active pharmaceutical ingredients (APIs) to over 60 countries. Its API manufacturing facilities undergo stringent inspections from regulatory authorities such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
Legacy MEDSearch
MARCH 1, 2024
Boston Scientific’s AGENT Drug-Coated Balloon (DCB) has been granted approval by the U.S. Food and Drug Administration (FDA) for treating coronary in-stent restenosis (ISR) in patients with coronary artery disease. While advancements in percutaneous coronary intervention (PCI) technologies are ongoing, recent research indicates that ISR, the gradual re-narrowing of a previously opened coronary artery, still occurs in up to one in 10 patients post-treatment.
Pharmaceutical Commerce
MARCH 1, 2024
A JAMA Network Open study dives into how the utilization of a digital patient portal changed during the COVID-19 pandemic, while also exploring ways that multimorbidity and socioeconomic disparities affected those statistics.
Cesare Ferrari
MARCH 1, 2024
After discussing value proposition in general and with respect to the customer and the product , in this post, I would use the value proposition canvas to analyze the value proposition of a medical product and its product market fit. Inclusively, I’ll evaluate the value proposition of hyaluronic acid injections with a specific customer segment in a defined context.
Pharmaceutical Commerce
MARCH 1, 2024
With its aims to protect healthcare consumers against the dangers of counterfeit, contaminated, stolen or otherwise harmful drugs, the DSCSA represents a significant step forward in securing the pharmaceutical supply chain.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
306 
Let's personalize your content